Alon MedTech Ventures

About The Fund

Alon MedTech Ventures is an investment firm specializing in the FinTech and Medical Devices industries. They focus primarily on early-stage ventures, allocating funds to innovative companies within their preferred sectors. Alon MedTech Ventures sets a minimum investment threshold of $100,000 and a maximum of $5,000,000, with their sweet spot for investment being around $1,500,000. They aim to support companies through Seed and Series A funding rounds, leveraging their expertise to foster growth and development in their portfolio companies. The firm prides itself on their specialized team, led by active chairman Dr. Shimon Eckhouse, who has a noteworthy history as an inventor, entrepreneur, and investor in the medical technology field. The team also includes VP of Business Development Assaf Mansour and CFO Michael Eden, each bringing their own extensive experience in investment, management, and business development. Their Chief Medical Officer, Dr. Ruthie Amir, contributes a strong background in clinical research and regulatory affairs, further strengthening the firm's ability to propel medical advancements. The portfolio of Alon MedTech features a variety of innovative medical technology ventures, such as Renaly, Supra, and Serenno Medical, each offering unique solutions and advancements in their respective areas, including therapeutic neuromodulation ultrasound technology, ophthalmic injectors, and urine output measuring devices. Additionally, companies like GerdCare and Cardiac Success reflect the fund's focus on medical electro-stimulation devices and cardiac implants. Alon MedTech's commitment to healthcare innovation is underscored by its support for ventures like Sequel Care, Levron Cardiovascular, Excita, Cherry Imaging, and Jubaan, which address challenges from mental health to image management in aesthetics and early detection of colon cancer. They also drive progress in neurology through NeuroIndex, aiming to avoid brain damage during surgical procedures. Their advisory board, comprising Dr. Adina Makover and Prof. Asher Barzilai, brings additional knowledge to the investment strategy, particularly in biotech and medical devices. With this rounded team and strategic approach, Alon MedTech Ventures aims to foster and scale ventures that can transform their target industries.